What is the current Veterinary Drug market size?

The current Veterinary Drug market size is approximately USD 25 billion as of 2022.

What is the growth forecast for the Veterinary Drug market?

The market is expected to grow at a CAGR of 7.8% from 2023 to 2028.

What are the key drivers of the Veterinary Drug market?

Increasing pet ownership and rising demand for animal health products drive the market.

What are the major challenges facing the Veterinary Drug market?

Stringent regulatory requirements and high research costs are significant challenges.

Which regions are the leaders in the Veterinary Drug market?

North America and Europe are the leading regions in the Veterinary Drug market.

Who are the top companies in the Veterinary Drug market?

Zoetis, Merck, and Eli Lilly are among the top companies in the Veterinary Drug market.

What are the future opportunities in the Veterinary Drug market?

Emerging markets and advancements in technology offer future growth opportunities.

How does technology impact the Veterinary Drug market?

Technological advancements improve drug development and manufacturing processes.

What is the regulatory landscape for the Veterinary Drug market?

Regulatory bodies such as FDA and EMA oversee the approval and monitoring of veterinary drugs.

What is the future outlook for the Veterinary Drug market?

The market is expected to experience steady growth driven by increasing demand for animal health products.

Veterinary Drug Market Metrics & Forecast Analysis 2033

Veterinary Drug by Application (Pets, Cattle, Poultry, Swine, Others), by Types (Anti-Infectives, Anti-Inflammatory, Parasiticides, Analgesics, Sedatives, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 139

Forecast Period: 2026 - 2033

Market Size: $35.2 million

CAGR: 6.4%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 139

Forecast Period: 2026 - 2033

Market Size: $35.2 million

CAGR: 6.4%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Veterinary Drug Market Overview

The veterinary drug market refers to the industry that produces and distributes medicines for the treatment and prevention of diseases in animals. As the global pet population continues to grow, the relevance of this market has increased significantly. The veterinary drug market size is estimated to be around $28 billion in 2025, with a growth outlook that is expected to drive the industry's expansion. The market forecast indicates a compound annual growth rate (CAGR) of 7.3% from 2026 to 2033, driven by macro drivers such as increasing pet ownership, rising demand for animal health products, and advancements in veterinary medicine.

Loading chart…

The industry expansion is expected to be driven by key forces such as technology shifts, regulations, and consumer behavior. The largest region in the veterinary drug market is North America, while the fastest-growing region is Asia-Pacific. The market is expected to be shaped by factors such as increasing demand for pet insurance, rising awareness about animal health, and growing competition among market players. As the market continues to evolve, it is essential for companies to stay ahead of the curve and adapt to the changing landscape.

Report Overview

Report Attribute	Details
Market size value in 2025	35.20 million
Revenue forecast in 2033	57.82 million
Growth rate	CAGR of 6.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Zoetis; Elanco Animal Health Incorporated; Boehringer Ingelheim; Merck Animal Health (a division of Merck & Co., Inc.); Virbac; Ceva Santé Animale; Vetoquinol S.A.; Dechra Pharmaceuticals PLC; Norbrook Laboratories Limited; Phibro Animal Health Corporation; Huvepharma AD; Hipra Animal Health; Ouro Fino Saúde Animal S.A.; CAHIC (China Animal Healthcare Industry Co., Ltd.); Orion Corporation; Ringpu Biology Co., Ltd.; Nippon Zenyaku Kogyo Co., Ltd.; Farmavet-Pasteur
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Veterinary Drug market is poised for significant growth, driven by increasing demand for animal health products and services. The Veterinary Drug market size is expected to expand substantially, with a growth forecast that underscores the industry's potential for innovation and development.

Growth Drivers2 items

Rising pet ownership and the subsequent increase in veterinary care expenditure are driving the demand for veterinary drugs, contributing to the growth of the Veterinary Drug market size.

Advances in veterinary medicine, including the development of new therapies and treatments, are further propelling the Veterinary Drug market forward, with a positive growth forecast anticipated in the coming years.

Restraints2 items

Stringent regulatory frameworks and the high cost of research and development are significant restraints on the Veterinary Drug market, potentially limiting the growth forecast and market size.

The risk of antibiotic resistance and the need for sustainable and environmentally friendly practices are also critical considerations for manufacturers in the Veterinary Drug market, impacting the industry's overall dynamics.

Opportunities2 items

The increasing adoption of veterinary telemedicine and digital health technologies presents opportunities for the Veterinary Drug market to expand its reach and improve access to care, contributing to a favorable growth forecast.

The growing demand for veterinary drugs in emerging markets, driven by rising incomes and changing lifestyles, is another key opportunity for the Veterinary Drug market to increase its size and scope.

Challenges2 items

The Veterinary Drug market faces challenges related to supply chain disruptions, pricing pressures, and competition from generic products, which can impact the growth forecast and market size.

Additionally, the industry must navigate complex and evolving regulatory landscapes, including those related to animal welfare and environmental sustainability, to ensure the long-term viability of the Veterinary Drug market.

Market Segmentation

Loading chart…

The Application segment in the Veterinary Drug market refers to the various uses of veterinary drugs in different animal species. This segment contributes significantly to the overall Veterinary Drug market size, as it encompasses a wide range of applications, including companion animals and livestock. The application segment is further divided into sub-segments, such as veterinary hospitals, clinics, and home care, each with its own unique characteristics and requirements. Understanding the Veterinary Drug segmentation by application is crucial for market players to develop targeted strategies and products that cater to the specific needs of different animal species and healthcare settings.

The Types segment in the Veterinary Drug market comprises various categories of drugs used in veterinary medicine, including pharmaceuticals, biologics, and medicated feed. This segment is critical in determining the overall Veterinary Drug market size, as different types of drugs have distinct market dynamics, growth prospects, and competitive landscapes. The types segment is further sub-divided into categories, such as antibiotics, anti-inflammatory agents, and vaccines, each with its own set of drivers, challenges, and opportunities. Analyzing the market taxonomy of veterinary drugs by type enables stakeholders to identify areas of growth, innovation, and investment in the Veterinary Drug market.

Veterinary Drug Segmentation Breakdown13 items

Application

Pets

Cattle

Poultry

Swine

Others

Types

Anti-Infectives

Anti-Inflammatory

Parasiticides

Analgesics

Sedatives

Others

Regional Insights

Loading chart…

The Veterinary Drug market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 35% of the market share, and also the fastest-growing region, driven by increasing adoption of veterinary drugs, favorable policies, and significant investments in the animal healthcare sector.

In North America, key drivers include a mature ecosystem, high demographics of pet owners, and a well-established infrastructure for veterinary care, with a regional forecast indicating a share of around 25%. Europe is driven by stringent policies and regulations, a strong pharmaceutical industry, and growing awareness about animal health, contributing to a share of approximately 20%.

Latin America and Middle East & Africa are expected to witness significant growth due to increasing demand for veterinary drugs, improving infrastructure, and rising investments in the animal healthcare sector, with estimated shares of around 10% and 10%, respectively.

Competitive Landscape

The Veterinary Drug competitive landscape is moderately consolidated, with a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The market is driven by companies that can balance these factors effectively, with global players like Zoetis and Elanco Animal Health Incorporated competing against regional companies. The Veterinary Drug key players are focused on navigating the complex regulatory environment and differentiating themselves through innovative products and services.

Common strategies employed by companies in this market include M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To stay competitive, companies must adapt to these challenges and focus on strategic initiatives that drive growth and profitability.

Zoetis: regional expansion

Elanco Animal Health Incorporated: innovation pipeline

Boehringer Ingelheim: vertical integration

Merck Animal Health: premium pricing

Virbac: local manufacturing

Ceva Santé Animale: OEM tie-ups

Key Veterinary Drug Companies18 items

Zoetis

Elanco Animal Health Incorporated

Boehringer Ingelheim

Merck Animal Health (a division of Merck & Co., Inc.)

Virbac

Ceva Santé Animale

Vetoquinol S.A.

Dechra Pharmaceuticals PLC

Norbrook Laboratories Limited

Phibro Animal Health Corporation

Huvepharma AD

Hipra Animal Health

Ouro Fino Saúde Animal S.A.

CAHIC (China Animal Healthcare Industry Co., Ltd.)

Orion Corporation

Ringpu Biology Co., Ltd.

Nippon Zenyaku Kogyo Co., Ltd.

Farmavet-Pasteur

Market Ecosystem

The Veterinary Drug ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of veterinary drugs, with each segment influencing the overall efficiency and effectiveness of the ecosystem. The Veterinary Drug ecosystem is characterized by a complex interplay of participants, each playing a distinct role in the value chain analysis.

Raw material suppliers — providing active pharmaceutical ingredients

OEMs / manufacturers — producing veterinary drugs

Distributors / channel partners — delivering products to end users

Regulators/standards bodies — overseeing compliance and safety

Service providers / after-sales — offering support and guidance

End users / buyers — veterinary clinics and animal owners

Data/analytics providers — informing product development and marketing

The flow of value within the Veterinary Drug ecosystem is influenced by control points, such as regulatory approvals and distributor networks, which can create bottlenecks and impact the adoption of new products. Dependency risks, including input constraints and standards compliance, can also affect the ecosystem's efficiency. Furthermore, switching costs, partnerships, and interoperability requirements can limit the flexibility of participants, while regional differences in regulations and market conditions can lead to variations in the ecosystem's structure and dynamics.

Recent Industry Insights

The Veterinary Drug industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships have been formed, such as collaborations between major pharmaceutical companies and veterinary research institutions, to develop innovative treatments for animal diseases. Furthermore, there have been several mergers and acquisitions, with companies expanding their product portfolios and strengthening their market presence. Recently, several new products and technologies have been launched, including advanced diagnostic tools and more effective vaccines.

Regulatory changes have also impacted the industry, with updated guidelines for the approval and marketing of veterinary drugs. Additionally, there has been a shift in consumer trends, with an increasing focus on animal health and wellness, driving demand for high-quality veterinary care and products. Funding rounds and expansions have also been announced, with companies investing in research and development to stay ahead of the competition and address emerging trends in the Veterinary Drug industry trends.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Veterinary Drug market. The market attractiveness is high, driven by increasing pet ownership and a growing demand for effective animal healthcare solutions. The competitive intensity is moderate, with key players investing in research and development to stay ahead in the market. The long-term outlook for the Veterinary Drug market outlook is positive, with opportunities for innovation in areas such as vaccine development and parasite control.

The innovation landscape is evolving, with a focus on developing new and more effective treatments. The demand-supply balance is stable, with manufacturers working to meet the growing demand for veterinary drugs. However, key risk factors such as regulatory changes and disease outbreaks must be carefully monitored. Overall, the Veterinary Drug market presents opportunities for growth and innovation, driven by increasing demand for animal healthcare solutions.

12 items

1. Executive Summary

2. Veterinary Drug Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Veterinary Drug Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Veterinary Drug Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Veterinary Drug Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Veterinary Drug Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Veterinary Drug Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Veterinary Drug Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Veterinary Drug Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Veterinary Drug Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Veterinary Drug Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Veterinary Drug Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Veterinary Drug Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Veterinary Drug Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Veterinary Drug Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Veterinary Drug Market Competition by Key Manufacturers

9.1. Global Veterinary Drug Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Veterinary Drug: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Zoetis

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Elanco Animal Health Incorporated

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Boehringer Ingelheim

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Merck Animal Health (a division of Merck & Co., Inc.)

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Virbac

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Ceva Santé Animale

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Vetoquinol S.A.

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Dechra Pharmaceuticals PLC

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Norbrook Laboratories Limited

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Phibro Animal Health Corporation

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Huvepharma AD

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Hipra Animal Health

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Ouro Fino Saúde Animal S.A.

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. CAHIC (China Animal Healthcare Industry Co., Ltd.)

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Orion Corporation

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Ringpu Biology Co., Ltd.

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Nippon Zenyaku Kogyo Co., Ltd.

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Farmavet-Pasteur

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Veterinary Drug Market

Figure 4: Global Veterinary Drug Market: Drivers

Figure 5: Global Veterinary Drug Market: Challenges

Figure 6: Global Veterinary Drug Market: Trends

Figure 7: Global Veterinary Drug Market: Opportunity

Figure 8: Global Veterinary Drug Market: Restraint

Figure 9: Global Veterinary Drug Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Veterinary Drug Market Value (USD Million) By Region

Figure 19: Global Veterinary Drug Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Veterinary Drug Market Value (USD Million) By Region

Figure 27: Global Veterinary Drug Market Share (%) By: Regions (2032)

Figure 28: Global Veterinary Drug Market Volume (K) By Region

Figure 29: Global Veterinary Drug Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Veterinary Drug Market Value (USD Million) By Region

Figure 37: Global Veterinary Drug Market Share (%) By: Regions (2032)

Figure 38: Global Veterinary Drug Market Volume (K) By Region

Figure 39: Global Veterinary Drug Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

131 items

Table 1: Market Segmentation Analysis

Table 2: Global Veterinary Drug Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Veterinary Drug Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Veterinary Drug Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Veterinary Drug Market Value (USD Million) By Region

Table 14: Global Veterinary Drug Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Veterinary Drug Market Volume (K) By Region

Table 31: Global Veterinary Drug Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Veterinary Drug Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Veterinary Drug Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Veterinary Drug Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Zoetis Basic Information And Sales Area

Table 52: Zoetis. Products Portfolio

Table 53: Elanco Animal Health Incorporated Basic Information And Sales Area

Table 54: Elanco Animal Health Incorporated. Products Portfolio

Table 55: Boehringer Ingelheim Basic Information And Sales Area

Table 56: Boehringer Ingelheim. Products Portfolio

Table 57: Merck Animal Health (a division of Merck & Co., Inc.) Basic Information And Sales Area

Table 58: Merck Animal Health (a division of Merck & Co., Inc.). Products Portfolio

Table 59: Virbac Basic Information And Sales Area

Table 60: Virbac. Products Portfolio

Table 61: Ceva Santé Animale Basic Information And Sales Area

Table 62: Ceva Santé Animale. Products Portfolio

Table 63: Vetoquinol S.A. Basic Information And Sales Area

Table 64: Vetoquinol S.A.. Products Portfolio

Table 65: Dechra Pharmaceuticals PLC Basic Information And Sales Area

Table 66: Dechra Pharmaceuticals PLC. Products Portfolio

Table 67: Norbrook Laboratories Limited Basic Information And Sales Area

Table 68: Norbrook Laboratories Limited. Products Portfolio

Table 69: Phibro Animal Health Corporation Basic Information And Sales Area

Table 70: Phibro Animal Health Corporation. Products Portfolio

Table 71: Huvepharma AD Basic Information And Sales Area

Table 72: Huvepharma AD. Products Portfolio

Table 73: Hipra Animal Health Basic Information And Sales Area

Table 74: Hipra Animal Health. Products Portfolio

Table 75: Ouro Fino Saúde Animal S.A. Basic Information And Sales Area

Table 76: Ouro Fino Saúde Animal S.A.. Products Portfolio

Table 77: CAHIC (China Animal Healthcare Industry Co., Ltd.) Basic Information And Sales Area

Table 78: CAHIC (China Animal Healthcare Industry Co., Ltd.). Products Portfolio

Table 79: Orion Corporation Basic Information And Sales Area

Table 80: Orion Corporation. Products Portfolio

Table 81: Ringpu Biology Co., Ltd. Basic Information And Sales Area

Table 82: Ringpu Biology Co., Ltd.. Products Portfolio

Table 83: Nippon Zenyaku Kogyo Co., Ltd. Basic Information And Sales Area

Table 84: Nippon Zenyaku Kogyo Co., Ltd.. Products Portfolio

Table 85: Farmavet-Pasteur Basic Information And Sales Area

Table 86: Farmavet-Pasteur. Products Portfolio

Table 87: Global Market Value (USD Million) (2025-2032) By Application

Table 88: Global Market Share (%) By Application (2032)

Table 89: Global Market Value (USD Million) (2025-2032) By Types

Table 90: Global Market Share (%) By Types (2032)

Table 91: Global Market Volume (K) (2025-2032) By Application

Table 92: Global Market Share (%) By Application (2032)

Table 93: Global Market Volume (K) (2025-2032) By Types

Table 94: Global Market Share (%) By Types (2032)

Table 95: Global Veterinary Drug Market Value (USD Million) By Region

Table 96: Global Veterinary Drug Market Share (%) By Region (2025-2032)

Table 97: North America Market Value (USD Million) (2025-2032) By Country

Table 98: North America Market Value (USD Million) (2025-2032) By Application

Table 99: North America Market Value (USD Million) (2025-2032) By Types

Table 100: Europe Market Value (USD Million) (2025-2032) By Country

Table 101: Europe Market Value (USD Million) (2025-2032) By Application

Table 102: Europe Market Value (USD Million) (2025-2032) By Types

Table 103: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 104: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 105: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 106: South America Market Value (USD Million) (2025-2032) By Country

Table 107: South America Market Value (USD Million) (2025-2032) By Application

Table 108: South America Market Value (USD Million) (2025-2032) By Types

Table 109: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 110: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 111: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 112: Global Veterinary Drug Market Volume (K) By Region

Table 113: Global Veterinary Drug Market Share (%) By Region (2025-2032)

Table 114: North America Market Volume (K) (2025-2032) By Country

Table 115: North America Market Volume (K) (2025-2032) By Application

Table 116: North America Market Volume (K) (2025-2032) By Types

Table 117: Europe Market Volume (K) (2025-2032) By Country

Table 118: Europe Market Volume (K) (2025-2032) By Application

Table 119: Europe Market Volume (K) (2025-2032) By Types

Table 120: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 121: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 122: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 123: South America Market Volume (K) (2025-2032) By Country

Table 124: South America Market Volume (K) (2025-2032) By Application

Table 125: South America Market Volume (K) (2025-2032) By Types

Table 126: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 127: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 128: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 129: Research Programs/Design For This Report

Table 130: Key Data Information From Secondary Sources

Table 131: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Veterinary Drug Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	35.20 million
Revenue forecast in 2033	57.82 million
Growth rate	CAGR of 6.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Zoetis; Elanco Animal Health Incorporated; Boehringer Ingelheim; Merck Animal Health (a division of Merck & Co., Inc.); Virbac; Ceva Santé Animale; Vetoquinol S.A.; Dechra Pharmaceuticals PLC; Norbrook Laboratories Limited; Phibro Animal Health Corporation; Huvepharma AD; Hipra Animal Health; Ouro Fino Saúde Animal S.A.; CAHIC (China Animal Healthcare Industry Co., Ltd.); Orion Corporation; Ringpu Biology Co., Ltd.; Nippon Zenyaku Kogyo Co., Ltd.; Farmavet-Pasteur
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising pet ownership and the subsequent increase in veterinary care expenditure are driving the demand for veterinary drugs, contributing to the growth of the Veterinary Drug market size.

Restraints2 items

Stringent regulatory frameworks and the high cost of research and development are significant restraints on the Veterinary Drug market, potentially limiting the growth forecast and market size.

Opportunities2 items

Challenges2 items

The Veterinary Drug market faces challenges related to supply chain disruptions, pricing pressures, and competition from generic products, which can impact the growth forecast and market size.

Market Segmentation

Loading chart…

Veterinary Drug Segmentation Breakdown13 items

Application

Pets

Cattle

Poultry

Swine

Others

Types

Anti-Infectives

Anti-Inflammatory

Parasiticides

Analgesics

Sedatives

Others

Regional Insights

Loading chart…

Competitive Landscape

Zoetis: regional expansion

Elanco Animal Health Incorporated: innovation pipeline

Boehringer Ingelheim: vertical integration

Merck Animal Health: premium pricing

Virbac: local manufacturing

Ceva Santé Animale: OEM tie-ups

Key Veterinary Drug Companies18 items

Zoetis

Elanco Animal Health Incorporated

Boehringer Ingelheim

Merck Animal Health (a division of Merck & Co., Inc.)

Virbac

Ceva Santé Animale

Vetoquinol S.A.

Dechra Pharmaceuticals PLC

Norbrook Laboratories Limited

Phibro Animal Health Corporation

Huvepharma AD

Hipra Animal Health

Ouro Fino Saúde Animal S.A.

CAHIC (China Animal Healthcare Industry Co., Ltd.)

Orion Corporation

Ringpu Biology Co., Ltd.

Nippon Zenyaku Kogyo Co., Ltd.

Farmavet-Pasteur

Market Ecosystem

Raw material suppliers — providing active pharmaceutical ingredients

OEMs / manufacturers — producing veterinary drugs

Distributors / channel partners — delivering products to end users

Regulators/standards bodies — overseeing compliance and safety

Service providers / after-sales — offering support and guidance

End users / buyers — veterinary clinics and animal owners

Data/analytics providers — informing product development and marketing

Recent Industry Insights

Analyst Overview

Table of Contents